AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6655232 — intervention group
Group type: COMPARATOR
Intervention: sham smoking under no stress
Number of subjects: 51
Study 6655232 — intervention group
Group type: COMPARATOR
Intervention: sham smoking under stress
Number of subjects: 51
Study 6655232 — intervention group
Group type: EXPERIMENTAL
Intervention: smoking under stress
Number of subjects: 51
Study 30985290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir with lamivudine or emtricitabine
Number of subjects: 58
Study 30985290 — intervention group
Group type: COMPARATOR
Intervention: Boosted darunavir with lamivudine or emtricitabine (Control)
Number of subjects: 58
Study 30985290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir with boosted darunavir
Number of subjects: 58
Study 30985290 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir with boosted darunavir (Control)
Number of subjects: 58
Study 29599299 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated electronic alert system
Number of subjects: 2278
Study 29599299 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2278
Study 27215949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) + Attention Control (AC)
Number of subjects: 70
Study 27215949 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD Education (COPD-ED) + Attention Control (AC)
Number of subjects: 70
Study 27215949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) + COPD Education (COPD-ED)
Number of subjects: 70
Study 27215949 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 70
Study 25057878 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal perchlorate levels in the highest 10% of the study population
Number of subjects: 487
Study 25057878 — intervention group
Group type: COMPARATOR
Intervention: Maternal levothyroxine therapy
Number of subjects: 487
Study 22393088 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiation therapy (RT)
Number of subjects: 12925
Study 19715709 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 13
Study 19715709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 16529712 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with fewer eating episodes
Number of subjects: 0
Study 16529712 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with more frequent eating episodes
Number of subjects: 0
Study 16529712 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study 15841764 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytate-reduced MCD and porridge (PR group)
Number of subjects: 300
Study 15841764 — intervention group
Group type: COMPARATOR
Intervention: Milk-based infant formula and porridge with regular phytate content (IF group)
Number of subjects: 300
Study 15841764 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial MCD and porridge (CC group)
Number of subjects: 300
Study 15841764 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with Hb < 110 g/l at 12 months
Number of subjects: 300
Study 15841764 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with S-Zn < 10.7 pmol/l at 12 months
Number of subjects: 300
Study 12508838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc-99m-DTPA aerosol scintigraphy
Number of subjects: 26
Study 12508838 — intervention group
Group type: EXPERIMENTAL
Intervention: Ga-67 scintigraphy
Number of subjects: 26
Study 9731046 — intervention group
Group type: COMPARATOR
Intervention: Study 03/87
Number of subjects: 57
Study 9731046 — intervention group
Group type: EXPERIMENTAL
Intervention: Study 04/89
Number of subjects: 57
Study 9731046 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cytarabine and mitoxantrone as consolidation in study 04/89
Number of subjects: 57
Study 9731046 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with t(4;11) and/or MLL-AF-4 rearrangements
Number of subjects: 57
Study 9731046 — intervention group
Group type: COMPARATOR
Intervention: Patients with 11q23 abnormalities
Number of subjects: 57
Study 8858275 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg on Days 1, 2, 3, 8, 15, 22, and 29)
Number of subjects: 40
Study 8858275 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg)
Number of subjects: 40
Study 8858275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8858275 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (sustained blood concentration of about 0.35 mg.ml-1)
Number of subjects: 40
Study 2179111 — intervention group
Group type: EXPERIMENTAL
Intervention: Podophyllin
Number of subjects: 450
Study 2179111 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 450
Study 2179111 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrodesiccation
Number of subjects: 450
Study 6986948 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 30
Study 6986948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31294473 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifying the prosthesis to allow for better oral hygiene (test group)
Number of subjects: 48
Study 31294473 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without modifying the prosthesis (control group)
Number of subjects: 48
Study 28321406 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta suppression/beta enhancement protocol
Number of subjects: 60
Study 28321406 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta suppression/alpha enhancement protocol
Number of subjects: 60
Study 25268968 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 162
Study 25268968 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 162
Study 25268968 — intervention group
Group type: COMPARATOR
Intervention: No-contact (control)
Number of subjects: 162
Study 24708597 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention (≥5 servings/day vegetables, ≥2 servings/day fruit, ≥8 ½ servings/day grains (mostly wholegrains), 3-4 servings/week lean meat) for 12 weeks
Number of subjects: 168
Study 24708597 — intervention group
Group type: COMPARATOR
Intervention: Standard dietary intake during pregnancy (control group)
Number of subjects: 168
Study 24708597 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention
Number of subjects: 168
Study 22914806 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin (ACT = 250 s)
Number of subjects: 60
Study 22914806 — intervention group
Group type: COMPARATOR
Intervention: Control group (full heparin dose, ACT = 420 s)
Number of subjects: 60
Study 19845769 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone with A118G variant allele
Number of subjects: 33
Study 19845769 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone with C3435T variant allele
Number of subjects: 33
Study 19845769 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone with G2677T/A variant allele
Number of subjects: 33
Study 19845769 — intervention group
Group type: COMPARATOR
Intervention: Combined wild-type genotype 3435CC-2677GG
Number of subjects: 33
Study 16868020 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-min walk test (6MWT)
Number of subjects: 163
Study 15775730 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (weekly)
Number of subjects: 297
Study 15775730 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee drinking
Number of subjects: 297
Study 15775730 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, BMI, caffeine intake, smoking, and exercise adjustments
Number of subjects: 297
Study 12410322 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training until an increase of more than 20 cm H2O is reached
Number of subjects: 30
Study 12410322 — intervention group
Group type: COMPARATOR
Intervention: Sham training (Control group)
Number of subjects: 30
Study 10613346 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg/day)
Number of subjects: 20
Study 10613346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7603812 — intervention group
Group type: EXPERIMENTAL
Intervention: WI79‐9 virus vaccine (10^7.3 plaque‐forming units in three oral doses separated by 2 months)
Number of subjects: 325
Study 7603812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study 2262643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryegrass allergen (incremental doses applied topically to one eye)
Number of subjects: 11
Study 2262643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryegrass allergen (higher antigen concentrations)
Number of subjects: 11
Study 2262643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryegrass allergen (320,000 BU/ml)
Number of subjects: 11
Study 2262643 — intervention group
Group type: COMPARATOR
Intervention: Buffer (applied to the other eye of ryegrass-sensitive patients)
Number of subjects: 11
Study 2262643 — intervention group
Group type: COMPARATOR
Intervention: Similar challenge to non-ryegrass-sensitive control subjects
Number of subjects: 11
Study 31118 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin + Urokinase (UK)
Number of subjects: 300
Study 31118 — intervention group
Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 300
Study 31118 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase (UK) in PE
Number of subjects: 300
Study 31100514 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 16–32 mg/kg/d infusion for 6 days
Number of subjects: 103
Study 31100514 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion for 6 days
Number of subjects: 103
Study 31100514 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 103
Study 31100514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 27198586 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training (EMST) at 70% threshold of maximum expiratory pressure, 5 days per week for 4 weeks, 25 breaths per day
Number of subjects: 24
Study 27198586 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with resistance-free sham device
Number of subjects: 24
Study 25188811 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management interventions, nurse visits, assistive technology, educational brochures
Number of subjects: 438
Study 23134570 — intervention group
Group type: EXPERIMENTAL
Intervention: 2009 pandemic (H1N1) vaccine containing 7.5 μg haemagglutinin (HA)
Number of subjects: 0
Study 23134570 — intervention group
Group type: EXPERIMENTAL
Intervention: 2009 pandemic (H1N1) vaccine containing 15 μg haemagglutinin (HA)
Number of subjects: 0
Study 23134570 — intervention group
Group type: COMPARATOR
Intervention: Seasonal influenza vaccine
Number of subjects: 0
Study 20473893 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriers of the rare T allele of the VDR gene (rs2228570)
Number of subjects: 5299
Study 20473893 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriers of the rare T allele of the VDR gene (rs2228570) among younger women (< 50 years)
Number of subjects: 5299
Study 20473893 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriers of the rare T allele of the VDR gene (rs2228570) among younger women (< 50 years) after excluding Hawaii data
Number of subjects: 5299
Study 19171723 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated case‐based physician learning intervention (group B)
Number of subjects: 2020
Study 19171723 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated case‐based learning intervention with physician opinion leader feedback (group C)
Number of subjects: 2020
Study 19171723 — intervention group
Group type: COMPARATOR
Intervention: No intervention (group A)
Number of subjects: 2020
Study 16845146 — intervention group
Group type: COMPARATOR
Intervention: Statins
Number of subjects: 0
Study 16845146 — intervention group
Group type: COMPARATOR
Intervention: Lipid-lowering therapy
Number of subjects: 0
Study 15596746 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (strength and aerobic training for 6 months)
Number of subjects: 95
Study 15596746 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 95
Study 11305513 — intervention group
Group type: COMPARATOR
Intervention: Tetanus toxoid vaccine (1 ml, 6 Lf units)
Number of subjects: 22
Study 9013434 — intervention group
Group type: EXPERIMENTAL
Intervention: NCEP Step I diet
Number of subjects: 409
Study 9013434 — intervention group
Group type: EXPERIMENTAL
Intervention: NCEP Step II diet
Number of subjects: 409
Study 9013434 — intervention group
Group type: EXPERIMENTAL
Intervention: NCEP Step I and II diets
Number of subjects: 409
Study 9275136 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated egg white
Number of subjects: 38
Study 9275136 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated and ovomucoid-depleted egg white
Number of subjects: 38
Study 9275136 — intervention group
Group type: COMPARATOR
Intervention: Freeze-dried egg white
Number of subjects: 38
Study 9275136 — intervention group
Group type: COMPARATOR
Intervention: Other proteins in egg white
Number of subjects: 38
Study 2719236 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural morphine
Number of subjects: 37
Study 2719236 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural morphine
Number of subjects: 37
Study 819598 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenine arabinoside
Number of subjects: 102
Study 819598 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluorothymidine
Number of subjects: 102
Study 31402008 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 3412
Study 31402008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3412
Study 26886047 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified dynamic orthosis
Number of subjects: 0
Study 26886047 — intervention group
Group type: COMPARATOR
Intervention: Conventional static orthosis
Number of subjects: 0
Study 26507494 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint stimulation + dexamethasone (Group Acu)
Number of subjects: 157
Study 26507494 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron + dexamethasone (Group Trp)
Number of subjects: 157
Study 26507494 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone alone (Group Dxm)
Number of subjects: 157
Study 23855415 — intervention group
Group type: EXPERIMENTAL
Intervention: Program SI! (intervention schools)
Number of subjects: 24
Study 23855415 — intervention group
Group type: COMPARATOR
Intervention: Normal curriculum (control schools)
Number of subjects: 24
Study 19081697 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI/spacer combination
Number of subjects: 60
Study 19081697 — intervention group
Group type: COMPARATOR
Intervention: Nebulizer
Number of subjects: 60
Study 18842256 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (x 21 days)
Number of subjects: 67
Study 18842256 — intervention group
Group type: COMPARATOR
Intervention: Placebo (x 21 days)
Number of subjects: 67
Study 16409529 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml x kg(‐1) x h(‐1) of lactated Ringer's solution (superhydration group)
Number of subjects: 100
Study 16409529 — intervention group
Group type: COMPARATOR
Intervention: 10 ml x kg(‐1) x h(‐1) of lactated Ringer's solution (control group)
Number of subjects: 100
Study 15282232 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored professional intervention including clinical practice guideline, educational outreach visit, and postal reminder.
Number of subjects: 1503
Study 15282232 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 1503
Study 11702916 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 m shuttle walk test (SWT)
Number of subjects: 0
Study 11702916 — intervention group
Group type: COMPARATOR
Intervention: 6 minute walk test (6WT)
Number of subjects: 0
Study 9135528 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline (2.5 micrograms/kg/min)
Number of subjects: 16
Study 9135528 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (25 micrograms/kg/min)
Number of subjects: 16
Study 9135528 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 16
Study 8109230 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg
Number of subjects: 34
Study 8109230 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.02 mg/kg
Number of subjects: 34
Study 8109230 — intervention group
Group type: COMPARATOR
Intervention: Halothane anesthesia (control)
Number of subjects: 34
Study 3292596 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin (epoprostenol) infused intravenously at a dose of up to 5 ng/kg/min for 72 hours with a tapering off period for the last 12 hours.
Number of subjects: 156
Study 3292596 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin (epoprostenol) in open-label fashion.
Number of subjects: 156
Study 3292596 — intervention group
Group type: COMPARATOR
Intervention: Placebo infused intravenously for the same duration and dosage as prostacyclin.
Number of subjects: 156
Study 30848576 — intervention group
Group type: EXPERIMENTAL
Intervention: M2000 (β-D-Mannuronic Acid), 500 mg two times a day for 6-8 weeks
Number of subjects: 24
Study 28349228 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 36
Study 28349228 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 36
Study 26250771 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol at 80 μg/day
Number of subjects: 97
Study 26250771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 24703369 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple complex plaques
Number of subjects: 3137
Study 24703369 — intervention group
Group type: COMPARATOR
Intervention: Single complex plaque
Number of subjects: 3137
Study 22000795 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-injection group (20 mL of 0.75% bupivacaine and 10 mL 98% alcohol)
Number of subjects: 50
Study 22000795 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-injection group (20 mL of 0.75% bupivacaine and 10 mL 98% alcohol)
Number of subjects: 50
Study 22000795 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 50
Study 18447921 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care plus total body cooling for 72 hours
Number of subjects: 325
Study 18447921 — intervention group
Group type: COMPARATOR
Intervention: Intensive care without cooling
Number of subjects: 325
Study 16140461 — intervention group
Group type: EXPERIMENTAL
Intervention: Male-to-female transsexuals (MFT)
Number of subjects: 63
Study 16140461 — intervention group
Group type: EXPERIMENTAL
Intervention: Female-to-male transsexuals (FMT)
Number of subjects: 63
Study 16140461 — intervention group
Group type: COMPARATOR
Intervention: Control males
Number of subjects: 63
Study 16140461 — intervention group
Group type: COMPARATOR
Intervention: Control females
Number of subjects: 63
Study 12919397 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 1
Study 10740548 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 5 mg ml-1 in 0.9% glucose solution
Number of subjects: 100
Study 10740548 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 5 mg ml-1 in 8% glucose solution
Number of subjects: 100
Study 10740548 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study 8824472 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pancreas-kidney transplantation (PKT)
Number of subjects: 22
Study 8824472 — intervention group
Group type: COMPARATOR
Intervention: Pancreas-kidney transplantation with pancreas failure (PKT-P)
Number of subjects: 22
Study 8824472 — intervention group
Group type: EXPERIMENTAL
Intervention: PKT
Number of subjects: 22
Study 1577940 — intervention group
Group type: EXPERIMENTAL
Intervention: Incubation for 24 h in T6 medium with 50% follicular fluid (v/v)
Number of subjects: 43
Study 1577940 — intervention group
Group type: EXPERIMENTAL
Intervention: Incubation for 24 h in T6 medium followed by electroporation and incubation for a few hours in T6 medium with 3.5 mM pentoxifylline
Number of subjects: 43
Study 1577940 — intervention group
Group type: EXPERIMENTAL
Intervention: Subzonal insemination of oocytes
Number of subjects: 43
Study 1577940 — intervention group
Group type: EXPERIMENTAL
Intervention: Subzonal insemination of fertilized oocytes
Number of subjects: 43
Study 1577940 — intervention group
Group type: EXPERIMENTAL
Intervention: Embryo replacement in cycles
Number of subjects: 43
Study 1577940 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal diagnosis by amniocentesis
Number of subjects: 43
Study 3156501 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic aspiration under general anesthesia
Number of subjects: 20
Study 3156501 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonically guided aspiration with local anesthesia
Number of subjects: 20
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet intervention (active intervention) for 6 months
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sustained continuation phase (SSP) of the intervention
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of olive oil
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Choosing olive oil as a type of fat
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of red and processed meats
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mMDS
Number of subjects: 48
Study 31546768 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient intake from FFQ
Number of subjects: 48
Study 30282688 — intervention group
Group type: EXPERIMENTAL
Intervention: LoDED strategy (using a single high-sensitivity troponin blood test with an undetectable cut-off and ECG findings)
Number of subjects: 594